We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 25, 2022

Effects of Age, Sex, and Bodyweight on Ocrelizumab-Related Neutropenia

Multiple Sclerosis and Related Disorders

 

Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis and Related Disorders
Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS)
Mult Scler Relat Disord 2022 Jul 03;[EPub Ahead of Print], H Hammer, N Kamber, M Pistor, L Diem, C Friedli, A Chan, R Hoepner, A Salmen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading